英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
nidor查看 nidor 在百度字典中的解释百度英翻中〔查看〕
nidor查看 nidor 在Google字典中的解释Google英翻中〔查看〕
nidor查看 nidor 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
    Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer Includes Adstiladrin side effects, interactions and indications
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
    Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)* and the AUA SUO Guidelines1 By the International Bladder Cancer Group (IBCG) for high-risk NMIBC after BCG failure for those seeking to avoid radical cystectomy 2
  • Treatment With ADSTILADRIN® (nadofaragene firadenovec-vncg)
    Adstiladrin is a prescription medicine for the treatment of adults with a type of cancer of the lining of the bladder called non-muscle invasive bladder cancer (NMIBC), that has not spread to other parts of the body, and that did not respond to treatment with Bacillus Calmette-Guérin (BCG)
  • Ferring Announces Update to NCCN Guidelines Expanding . . .
    ADSTILADRIN ® (nadofaragene firadenovec-vncg) is an FDA-approved intravesical non-replicating gene-therapy for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors (±Ta T1)
  • What are the most recent research results on Adstiladrin . . .
    Use of Rectal Diazepam to Prevent Bladder Spasms and Leakage of Medication During Intravesical Administration of Nadofaragene Firadenovec for Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer
  • Adstiladrin | European Medicines Agency (EMA)
    The full indication is: Adstiladrin is indicated as monotherapy for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours Adstiladrin will be available as a 3 x 10 11 viral particles ml intravesical suspension
  • ADSTILADRIN | FDA
    ADSTILADRIN is indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in situ (CIS
  • Adstiladrin (Nadofaragene Firadenovec-Vncg) for bladder . . .
    Adstiladrin is also called nadofaragene firadenovec-vncg Adstiladrin is a gene therapy that uses a non-replicating adenoviral vector (a modified virus that cannot multiply) to deliver a gene to bladder cells This gene makes a protein called interferon alfa-2b, which activates the immune system to fight cancer cells How do I take it?
  • Nadofaragene Firadenovec-vncg - NCI - National Cancer Institute
    Nadofaragene firadenovec-vncg is approved to treat: Non-muscle–invasive bladder cancer with carcinoma in situ It is used in adults whose cancer does not respond to treatment with bacillus Calmette-Guérin (BCG) and has a high risk of coming back Nadofaragene firadenovec-vncg is also being studied in the treatment of other types of cancer
  • Nadofaragene Firadenovec-vncg (Adstiladrin®- Given into the . . .
    About Nadofaragene Firadenovec-vncg (Adstiladrin®- Given into the bladder) Nadofaragene Firadenovec-vncg is a non-replicating adenoviral vector-based gene therapy The treatment delivers the human interferon alfa-2b gene, which is non-replicating, to the cells in your bladder wall The interferon alfa-2b gene has anti-tumor effects





中文字典-英文字典  2005-2009